Article
Hereditary Syndromes in Neuroendocrine Tumors.
Current treatment options in oncology - 30 Apr 2020
Lewis Mark A
Abstract excerpt
OPINION STATEMENT: Oncologists should be able to discern the salient clinical features of the most common germline mutations that give rise to neuroendocrine tumors. Astute recognition of an index patient affected by a hereditary syndrome can lead to a "tip-of-the-iceberg" phenomenon whereby their entire kindred can then be proactively monitored and managed potentially with substantial reduction of morbidity and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
